Clinical Trial: Study of VXCO-100, a SARS-CoV Candidate Vaccine in Healthy Adults in the United States
Study Status: ACTIVE_NOT_RECRUITING
Recruit Status: ACTIVE_NOT_RECRUITING
Condition: SARS-CoV
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Open-Label, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of VXCO-100 in Healthy Adults in the United States
Brief Summary:
The purpose of this study is to evaluate the safety and immunogenicity of ascending dose levels of VXCO-100 in healthy adults.
Read more